ArticleOdontology2026
The effect of activation of the sequential use of ethylenediaminetetraacetic acid and octenidine dihydrochloride on the release of TGF-β1 in regenerative endodontic treatments.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The aim of this study is to assess the effect of ultrasonic (PUI) and sonic (EDDY) activation of the sequential use of ethylenediaminetetraacetic acid (EDTA) and octenidine dihydrochloride (OCT) on the release of transforming growth factor beta-1 (TGF-β1) from dentin in regenerative endodontic treatments (RET). Seventy-two extracted were decoronated and prepared to an apical diameter of 1 mm to replicate an immature teeth. Each specimen was initially irrigated with 20 mL of 1.5% sodium hypochlorite according to the RET protocol. Samples were assigned to three main irrigant groups (n = 24): 17% EDTA, 0.1% OCT, and 17% EDTA followed by 0.1% OCT. Each main group was further divided into three subgroups (n = 8) based on activation technique-syringe-needle irrigation (SNI), PUI, and EDDY. Levels of TGF-β1 released on days 1 and 7 were quantified by ELISA, and smear layer removal was analyzed under scanning electron microscopy (SEM). Statistical significance was established at p < 0.05. SEM analysis revealed varying degrees of smear layer removal in all groups. The combination of EDTA and OCT resulted in significantly higher TGF-β1 release compared to the use of either solution alone in all activation groups (p < 0.05). TGF-β1 levels were significantly higher at day 7 than day 1 (p < 0.05). EDDY activation with the sequential use of EDTA and OCT yielded the highest TGF-β1 levels and the greatest percentage increase (p < 0.05). Biocompatible irrigation solutions and enhanced activation systems could improve the release of growth factors from dentin, thereby potentially contributing to the overall success of RETs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.